FDA Investigator Nancy M Espinal

Nancy M Espinal has conducted inspections on 68 sites in 6 countries as of 08 Dec 2022. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
68
Last Inspection Date:
08 Dec 2022
Investigator Role:
FDA Investigator
Redica ID:
100000698
Countries of Inspections:
United States of America, China, France, Korea (Republic of), India, Belgium
FDA Investigators that have inspected at least one site in common with Nancy M Espinal:
Addam S Reynolds, Adetutu M Gidado, Alicia M Mozzachio, Alison N Stieg, Amy C Jordan, Amy Chen, Amy L Singer, Amy M Cramer, Amy N Chen, Anastasia I Offordile, Anastasia I Onuorah, Anastasia M Shields, Andrew J Barrowcliff, Andrew M Barlow, Ankur C Patel, Annemarie B Randow, Annemarie Bodnar, Atul J Agrawal, Azeezat M Lawal, Azza Talaat, Barbara Jwilimczyk Macri, Bijoy Panicker, Brandy N Lepage, Brenna L Macdowell, Brooke K Higgins, Brooke K Seeman, Bryan L Mcguckin, Byungja E Marciante, Carl A Anderson, CDR Ileana Barreto Pettit, Chaltu Nwakijra, Charanjeet Jassal, Charles R Cote, RIC, Christian F Gomez Lugo, Christina K Theodorou, Christopher R Czajka, Constantin Y Philopoulos, Daniel J Grabicki, Daniel J Min, Daniel L Obrzut, Daniel L Zheng, David A Carlson, David A Oluwo, David R Heiar, Dawn L Wydner, Denise M Visco, Investigator, Dennis Cantellops Paite, Dennis L Doupnik, Devon Jenkins, Dhaval H Patel, Diane C Thibodeau, Diane T Bargo, Diane T O'brien, Donald L Lech, Doreen P Gubbay, Dorothy J Denes, Douglas A Campbell, Douglas C Kovacs, Dr. Robert C Horan, MD, Elaine E Gilfillan, Emest F Bizjak, Emmanuel Jramos Maldonado, Eric Rothschild, Erika V Butler, Erin D Mccaffery, Esteban Beltran, Farhana Khan, Frank J Marciniak, Frederick F Razzaghi, George J Flynn, Gianine E Tompkins, Guerlain Ulysse, Helen Verdel, Himanshu Gupta, PhD, Jaison J Eapen, James C Maclaughlin, James D Bridges, James M Mason, James R Birkenstamm, Janet A Rajan, Jason K Morgan, Jay T Wong, Jean M Kelahan, Jennifer L Huntington, Jennifer Macmillan, Jeremy W Rotton, Jessica M Monteiro, Jessica S Estriplet, Joanne E King, Joanne M Schlossin, Jogy George, John P Mistler, Johnna L Bleem, Jonathan G Matrisciano, Jonathan W Chapman, Jose Acruz Gonzalez, José E Meléndez, Jose M Cayuela, Joseph F Mcginnis, RPh, Joseph J Vannelli, Joy Rkozlowski Klena, Juanita P Versace, June P Page, Junho Pak, Justin A Boyd, Justine Tomasso, Karen A Briggs, Karen E D'orazio, Karen F Tomaziefski, Karen L Kosar, Karishma G Gopaul, Katelyn Astaub Zamperini, Katherine Szestypalow, Kelli F Dobilas, Kellia N Hicks, Kenneth R Merritt, Kevin P Foley, Kinh Q Mac, Ko U Min, Kristen E Rescigno, Kristina L Conroy, Kristy A Zielny, Krystyna M Kitson, Kshitij A Patkar, Lata C Mathew, PhD, Laura L Staples, Lauren L Vajo, Lawrence Harmon, Jr, Lawrence J Stringer, Liatte Kreuger, PharmD, Lisa M Bellows, Loretta Nemchik, Lori M Newman, Luella J Rossi, Luis A Dasta, Marcelo O Mangalindan, Jr, Marcus A Ray, Marea K Harmon, Margaret M Sands, Maria Estrella, Marie F Morin, Massoud Motamed, Matthew D Schnittker, Mayar M Mussa, Melissa A Freeman, Melissa B Libby, Melissa J Garcia, Melissa T Roy, Melkamu Getie Kebtie, PhD, Meredith L Sheridan, Meyer J Slobotsky, Michael A Charles, Michael A Taylor, Michael L Chasey, Michael R Goga, Michael R Klapal, Michael Serrano, Michael W Burd, Michele Gottshall, Michelle Marsh, Mindy M Chou, Monica Cburgos Garcia, Monika Borkowska, Muralidhara B Gavini, PhD, Nancy F Scheraga, Nancy L Rolli, Natasha Gupta, Nerizza B Dalena, Nerizza B Guerin, Nicholas A Violand, Nicole E Knowlton, Nije A Thomas, Niketa Patel, Nikisha M Bolden, Nikki S Ramirez, Nina Ni, Nina Yang, Pal S Mayasandra, Pankaj H Amin, Patrick C Klotzbuecher, Paul L Bellamy, Paula J Bretz, Philip Kreiter, Pratik S Upadhyay, DDC, Puspa Suresh Jayasekara, Qin Xu, Rabin N Ghoshal, Rachael O Oyewole, Rajiv R Srivastava, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Richard E Needham, Richard K Glabach, Rita K Kabaso, Robert D Tollefsen, Robert J Martin, Robert O'brian, Robert W Calais, Robin P Mathew, Rochelle L Cross, Rosario D'costa, Rose Ljean Mary, Russell J Glapion, Saleem A Akhtar, Sandra A Boyd, Sarah Adella Fave, Sarah Forney, Sayyem H Akbar, Sean G Casey, Sean R Marcsisin, Sena G Dissmeyer, Sherry G Bous, Shirley S Wen, Sneha S Patel, Sony Mathews, Srinivas R Chennamaneni, PhD, Stephanie T Durso, Stephen J Koniers, Stephen J Mottola, Steven M Weinman, Steven P Donald, Suchan Kim, Susan M Jackson, Syeda N Mahazabin, Tamika White, Tamil Arasu, PhD, Tara G Bizjak, Thomas J Arista, Thomas P Hansen, Thomas Thomas, Nije A, Timothy T Kapsala, Toyin B Oladimeji, Truong Xuan Nguyen (Andy), Unnee Ranjan, Vivin George, William A Warnick, William J Muszynski, William L Bargo, William R Chang, Xikui Chen (nmi), PhD, Yoriann M Cabrera Bartolomei, Yvesna C Blaise, Yvins Dezan, Zhongren Wu

Nancy M Espinal's Documents

Publish Date Document Type Title
June, 2017 FDA 483 C. O. Truxton Inc. - Form 483, 2017-06-01
October, 2018 EIR TPM Laboratories, Inc. - EIR, 2018-10-16
October, 2020 FDA 483 Curexa - East, LLC dba Curexa - Form 483, 2020-10-09
November, 2019 FDA 483 TENTAMUS INDIA PRIVATE LIMITED - Form 483, 2019-11-01
August, 2021 FDA 483 Teligent, Inc. - Form 483, 2021-08-31
January, 2018 EIR Veranova, L.P. - EIR, 2018-01-31
March, 2020 FDA 483 KVK-TECH, INC - Form 483, 2020-03-13
August, 2019 FDA 483 CooperSurgical, Inc. - Form 483, 2019-08-01
August, 2019 EIR Specialty Minerals Incorporated - EIR, 2019-08-22
November, 2016 FDA 483 InvaTech Pharma Solutions LLC - Form 483, 2016-11-08
November, 2018 FDA 483 Shiseido America Inc. - Form 483, 2018-11-01
December, 2018 EIR Siegfried USA, LLC - EIR, 2018-12-19
October, 2021 FDA 483 Symed Labs Limited - Form 483, 2021-10-16
June, 2019 FDA 483 Reviva Labs Inc - Form 483, 2019-06-21
June, 2016 FDA 483 Village Pharmacy - Form 483, 2016-06-22
April, 2016 FDA 483 Alliance Technologies, LLC - Form 483, 2016-04-15
September, 2019 EIR AptaPharma Inc. - EIR, 2019-10-23
November, 2015 FDA 483 Cetylite Industries, Inc. - Form 483, 2015-11-19
July, 2019 FDA 483 Mandell's Clinical Pharmacy - Form 483, 2019-07-25
December, 2015 EIR The Jet Pulverizer Company - EIR, 2015-12-21
October, 2019 FDA 483 SHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH - Form 483, 2019-10-22
March, 2016 FDA 483 SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483, 2016-03-14
August, 2019 FDA 483 Specialty Minerals Incorporated - Form 483, 2019-08-22
October, 2017 EIR Teligent, Inc. - EIR, 2017-10-19
August, 2017 FDA 483 Novel Laboratories, Inc. - Form 483, 2017-08-08
April, 2016 FDA 483 Akorn Operating Company LLC (dba Akorn) - Form 483, 2016-04-04
September, 2019 FDA 483 AptaPharma Inc. - Form 483, 2019-09-25
October, 2017 FDA 483 Response Teligent, Inc. - Form 483R, 2018-02-06
August, 2017 FDA 483 Response Novel Laboratories, Inc. - Form 483R, 2017-11-30
April, 2017 FDA 483 InvaTech Pharma Solutions LLC - Form 483, 2017-04-04
August, 2017 FDA 483 Mylan Pharmaceuticals Inc. - Form 483, 2017-08-25
July, 2016 FDA 483 Response Actavis LLC - Form 483R, 2016-07-28
October, 2017 FDA 483 Teligent, Inc. - Form 483, 2017-10-19
July, 2016 FDA 483 Actavis LLC - Form 483, 2016-07-07
April, 2016 FDA 483 Response Akorn Operating Company LLC (dba Akorn) - Form 483R, 2016-04-26
February, 2017 FDA 483 Novel Laboratories, Inc. - Form 483, 2017-02-14
June, 2017 EIR C. O. Truxton Inc. - EIR, 2017-06-01
January, 2018 FDA 483 Veranova, L.P. - Form 483, 2018-01-31
October, 2021 FDA 483 Dr Reddy's Laboratories Limited - Form 483, 2021-10-29
January, 2018 FDA 483 Response Veranova, L.P. - Form 483R, 2018-02-21
September, 2021 FDA 483 LUPIN LIMITED - Form 483, 2021-09-18
December, 2018 FDA 483 Siegfried USA, LLC - Form 483, 2018-12-19
December, 2018 FDA 483 Response Siegfried USA, LLC - Form 483R, 2019-01-10
May, 2019 FDA 483 Response Teligent, Inc. - Form 483R, 2019-11-11
July, 2016 EIR Actavis LLC - EIR, 2016-07-07
March, 2019 FDA 483 Veranova, L.P. - Form 483, 2019-03-08
December, 2015 FDA 483 L'OREAL USA, INC. - Form 483, 2015-12-09
December, 2022 FDA 483 CIS Bio International - Form 483, 2022-12-16
May, 2019 FDA 483 Teligent, Inc. - Form 483, 2019-05-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more